French seed firm strikes gene editing licensing deal, despite CRISPR’s uncertain future in EU

Image: Hoosier Ag Today

Despite the ongoing legal uncertainty over the future of new plant breeding innovation in Europe, US agricultural company Corteva Agriscience has signed its first major deal on genome editing tools with French seed producer Vilmorin & Cie.

The French company issued a press release on Monday (9 December) announcing the signature of an agreement on genome editing tools with Corteva Agriscience and the Broad Institute of MIT and Harvard, a biomedical and genomic research center.

The licensing deal will provide the French company with access to certain CRISPR-Cas9 patents covering genome editing tools for agricultural use.

“Vilmorin & Cie now has access to a wide range of genome editing tools, which will enable it to strengthen its ability to develop more efficient seed varieties in order to contribute to meeting global food challenges,” the company said.


The gene-editing deal is considered of high significance in light of the ongoing debate in Europe about the regulatory future of gene editing.

Related article:  Roundup on trial: Second glyphosate-cancer lawsuit heads to federal court

Read full, original article: Corteva signs first major gene editing deal with European company

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend